loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 21365 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    AbbVie Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ABBVIE (1)

    filter

    01 SOLUTION;ORAL (1)

    filter

    01 DISCN (1)

    filter

    01 LEXAPRO (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ESCITALOPRAM OXALATE

    PDF Supplier PDF
    URL Supplier Web Content
    SOLUTION; ORAL
    EQ 5MG BASE/5ML **...
    2002-11-27
    21365
    LEXAPRO
    DISCN
    Yes
    Abbvie Company Banner

    Cophex 2024

    Not Confirmed

    envelop Contact Supplier

    Looking for FDA Orange Book APPLICATION 21365

    Looking for FDA Orange Book APPLICATION 21365 1

    19

    AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ESCITALOPRAM OXALATE, with a corresponding application number 21365.

    Regulatory Information DISCN

    With a dosage strength EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Dosage Form Route SOLUTION; ORAL

    Reference Listed Drug Yes

    Approved since 2002-11-27

    Post Enquiry
    POST ENQUIRY